MUFG Americas
MYOK

MUFG Americas’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

MUFG Americas’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-353
Closed -$15K – 1189
2017
Q3 		$15K Buy
+353
New +$11.3K ﹤0.01% 800

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

MUFG Americas's MYOK Position: Q4 2017 in Review

MUFG Americas sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2017, closing a stake of 353 shares — an estimated $15K sold.

MUFG Americas first reported a position in MYOK in Q3 2017 and held it in 1 quarter. The position peaked at $15K in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

  • MUFG Americas reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • MUFG Americas sold 353 MyoKardia, Inc. Common Stock shares in Q4 2017, an estimated $15K.
  • MUFG Americas first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • MUFG Americas's MyoKardia, Inc. Common Stock position peaked at $15K in Q3 2017.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on MUFG Americas's 13F filing for Q4 2017, filed 8 Feb 2018.